JILL ROGERS: Open Payments
NPI 1851744718 · PINEVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 14 payments from 8 companies in 2025. Trend: 2023 $614 · 2024 $591 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $138 |
| Novo Nordisk Inc | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
Products named: SPRAVATO, Wegovy, REXULTI, CAPLYTA, BREZTRI, FANAPT, XIFAXAN, The Cologuard Plus Collection Kit.
Industry payments across MO — which companies pay providers there.
